A Review of the Toxicologic Implications of Obesity
- PMID: 26108709
- PMCID: PMC4547963
- DOI: 10.1007/s13181-015-0488-6
A Review of the Toxicologic Implications of Obesity
Abstract
The increasing prevalence of obesity in developed nations has far-reaching implications for medical toxicology. The management of obese patients is complicated by comorbid illnesses, changes in cardiovascular and respiratory physiology, alterations in pharmacokinetics, and a lack of studies to identify appropriate dosing for current therapeutics and antidotes. In this review article, we examine obesity-associated physiologic and pharmacokinetic changes that may increase the vulnerability of obese patients to overdose. Further research is needed to characterize the relationship between drug toxicity and obesity.
Figures
References
-
- Freedman DS, CDC Obesity—United States, 1988–2008. MMWR Surveill Summ. 2011;60(Suppl):73–7. - PubMed
-
- May AL, Freedman D, Sherry B, Blanck HM, CDC Obesity—United States, 1999–2010. MMWR Surveill Summ. 2013;62(Suppl 3):120–8. - PubMed
-
- Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985–3023. doi: 10.1016/j.jacc.2013.11.004. - DOI - PubMed
-
- Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii, 1–253. - PubMed
-
- Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr. 1998;68(4):899–917. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
